About
I build accountability infrastructure for AI decisions — evidence traceability, reconsideration control, and override systems that survive institutional review.
I make sure that when a system is wrong, someone can trace why, challenge it, and fix it.
Quick version · 30 seconds
- Epic 2012–2013 · Configured EHR workflows, reduced alert fatigue.
- CTCA / CancerCompass 2019–2021 · Directed digital products — 30MM annual visitors, bounce rate −25%.
- Andwise 2022–2024 · Co-founded, raised $240K, grew to 1,200+ physician users.
Patients don't answer calls from unknown numbers. That single observation drove Doximity Dialer. As early product lead, I built a HIPAA-conscious calling tool that masked personal numbers, preserved carrier identity rules, and routed missed calls through verified fallback paths. iOS app reviews climbed from 3.7 to 4.8 stars during mobile product work. Doximity later reported that Dialer enabled 110M+ video and audio visits from 300K+ active clinicians.
At CancerCompass / CTCA Marketplace, I led digital products for an oncology navigation platform serving 30MM annual visitors (CTCA was later acquired by City of Hope). Internal analytics showed product changes cut bounce rate by 25% and lifted chat conversions 267%. At Transcarent, I directed product across value-based specialty-care and navigation programs (Surgery, Urgent Care, Behavioral Health, Oncology Care). Later, as co-founder and CEO of Andwise, I raised $240K in initial funding, grew to 1,200+ physician users and a 700-member community, and convened a 50+ physician medical advisory board.
At Epic, I configured EHR workflows where a single misrouted alert could bury a critical lab result. As an Implementation Engineer, I configured workflows and rollout quality metrics to reduce alert fatigue without compromising safety. The workflow around the clinician was usually the constraint, not the clinician.
At Georgia Tech, I studied RNA folding dynamics and sRNA-mRNA interactions in Roger Wartell's lab, modeling free energy barriers that determine whether reactions proceed or stall. I co-authored an ACS Symposium Series book chapter on sRNA-mRNA interactions at 19, and spent a summer on thoracic surgery outcomes at Memorial Sloan Kettering.
Across molecular biology, EHR configuration, clinician tools, oncology navigation, and financial support, one pattern held: high-stakes decisions become opaque once embedded in software. As U.S. healthcare shifts clinical judgment to algorithms, responsibility must move alongside it. I write about AI governance at The Crumple Zone and publish open standards at Ethotechnics to ensure automated decisions remain auditable in production.
See also
Evidence ledger
Every claim on this page is classified by evidence level. Public sources, self-reported metrics, and anonymized outcomes are separated. This is the same traceability discipline I apply to AI decisions in production.
Public source
Doximity Dialer launched as a physician calling product.
Public launch evidence for the product context.
Public source
Doximity later reported 110M+ video and audio visits from 300K+ active clinician users.
Company-reported scale after my early product work on Dialer.
Public source
Dialer integrated with Epic Haiku and appears in Epic Showroom.
Public interoperability trail for the Dialer ecosystem.
Mixed
CancerCompass / CTCA Marketplace digital product work and CTCA acquisition context.
Acquisition is public; traffic and conversion deltas are self-reported internal analytics.
Public source + anonymized outcomes
Transcarent Oncology Care launched while I led specialty-care and care-navigation product work.
Public link establishes program context; routing and completion outcomes are anonymized.
Public source
Andwise was co-founded by Kanav Jain and Dr. Varun Verma in 2022.
Public founder and company context.
Self-reported
Andwise reached $240K initial funding, 1,200+ physician users, and a 700-member community.
Kept separate from public founder and advisory-board proof.
Public source
ACS Symposium Series research chapter on sRNA-mRNA interactions and Hfq.
Publication-context evidence for early systems research background.
Current public practice
Ethotechnics and The Crumple Zone are current method and writing practices.
Methodology and research positioning, distinct from shipped-product proof.
Milestones
RNA folding published
Co-authored a book chapter in the ACS Symposium Series on sRNA-mRNA interactions and Hfq.
How I approach product work
Care as default
If a workflow requires someone to remember a step at 3AM, the step is the problem, not the person.
Evidence over lore
Watch how operators actually work. Instrument what matters, even when it's hard to measure.
Trustworthy automation
Every automated decision needs a visible override path. People can see who can pause it, what changed, and what to do if it is wrong.
Areas of focus
Education
B.S. Biomedical Engineering (with honors)
Georgia Institute of Technology
Human-centered clinical systems, pairing biomechanics and design research.
MBA
NYU Stern School of Business
Finance and technology focus, paired with product leadership in regulated markets.